These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30773273)

  • 21. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
    Kenzel S; Hufnagel M; Berner R; Henneke P
    Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases.
    O'Brien KL; Santosham M
    Am J Epidemiol; 2004 Apr; 159(7):634-44. PubMed ID: 15033641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal disease in childhood.
    Mohan PV; Heath PT
    Hosp Med; 2001 Jul; 62(7):406-9. PubMed ID: 11480127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal vaccines WHO position paper--2012.
    Wkly Epidemiol Rec; 2012 Apr; 87(14):129-44. PubMed ID: 24340399
    [No Abstract]   [Full Text] [Related]  

  • 26. The preventable burden of pneumococcal disease in the developing world.
    Scott JA
    Vaccine; 2007 Mar; 25(13):2398-405. PubMed ID: 17028081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
    Madhi SA; Bamford L; Ngcobo N
    S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Epidemiology and Biostatistics of Pneumococcus.
    Oligbu G; Fry NK; Ladhani SN
    Methods Mol Biol; 2019; 1968():215-224. PubMed ID: 30929218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
    Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
    Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study.
    Moulton LH; O'Brien KL; Reid R; Weatherholtz R; Santosham M; Siber GR
    J Biopharm Stat; 2006; 16(4):453-62. PubMed ID: 16892907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 33. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
    Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
    Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA.
    Tan TQ
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):117-25. PubMed ID: 20109042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    De Wals P; Lefebvre B; Markowski F; Deceuninck G; Defay F; Douville-Fradet M; Landry M
    Vaccine; 2014 Mar; 32(13):1501-6. PubMed ID: 24486346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014.
    Howitz MF; Harboe ZB; Ingels H; Valentiner-Branth P; Mølbak K; Djurhuus BD
    Vaccine; 2017 Oct; 35(43):5858-5863. PubMed ID: 28928078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The scope for pneumococcal vaccines that do not prevent transmission.
    Flasche S
    Vaccine; 2017 Oct; 35(45):6043-6046. PubMed ID: 28982625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: a 16-year study.
    Torzillo PJ; Morey F; Gratten M; Murphy D; Matters R; Dixon J
    Vaccine; 2007 Mar; 25(13):2375-8. PubMed ID: 17030079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.
    Yildirim I; Shea KM; Pelton SI
    Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.